Weekly Executive & Director Moves (Oct 06)

by | Oct 6, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

AADI, ACAH, ACCO, AGTI, AI1, AKLI, BV, CELL, CENT, CRMT, DHI, EWCZ, FARM, FRTX, IMNM, KZR, LAZ, NIR, PBI, PRFT, SAIC, SPR, SPSC, SYNH, VVV

CFO

ACAH, ACLS, AEP, AXNX, BAX, CG, EWBC, FARM, ILPT, MYFW, NIR, NRXP, NVTA, ORGN, OTTR, PODD, SEM, SIGI, SLAM, SMTC, SNDR, SYM, TIO, TMP, TRUE, VIAV, XELA

Directors

AADI, AAN, ACAH, ACCO, ADTN, AEP, AESI, AGTI, AKA, AKLI, AMPY, APO, BL, BMBL, BNMV, BRBR, BY, CELL, CNP, COR, CVS, DAL, DRI, EBS, ELDN, ENVX, EOSE, ESTC, EWCZ, FARM, FFIV, FIX, FLO, FRTX, GES, GTHX, HII, HWM, IGMS, IMNM, ITT, KRMD, KZR, LAZ, LAZY, LIVN, LRMR, MCRB, MIGI, NEOG, NLY, OBT, OFIX, OFLX, OSTK, PBI, PCTY, PHUN, PINC, PPG, QUAD, RF, RGA, RWT, RXT, RYAM, SABS, SAIC, SBUX, SKYT, SNX, SOND, SONO, SPR, SPSC, SR, SYRS, TCMD, TFC, THRM, TIO, TLYS, TT, UEIC, VRTX, VVV, XRAY

CEO Moves

AADI BIOSCIENCE INC (AADI)
Leaving: CEO – Scott M Giacobello ( .6 yrs; -56.7% TSR)
Replaced by: David James Lennon

Prior to joining the Company, Dr. Lennon, 52, served as Chief Executive Officer of Satellite Bio, a privately held regenerative medicine company, from July 2021 to September 2023. Prior to that, Dr. Lennon spent more than 15 years with Novartis AG, where he served most recently as President, Novartis Gene Therapies, and was responsible for the development, approval and launch of Zol…read full bio

ACCO BRANDS CORP (ACCO)
Leaving: CEO – Boris Elisman ( 10.6 yrs; -1.4% TSR)
Replaced by: Thomas W Tedford

Mr. Tedford joined ACCO Brands in 2010 and was named President and Chief Operating Officer in 2021. From 2011 to 2021, Mr. Tedford served first as Executive Vice President and President of ACCO Brands Americas ultimately becoming Executive Vice President and President, ACCO Brands, North America. During his tenure, he successfully led the operational, cultural and leadership integrations of key st…read full bio

AGILITI INC (AGTI)
Leaving: CEO – Thomas W Boehning ( .5 yrs; -58.9% TSR)
Replaced by: Thomas J Leonard

Thomas J. Leonard has been a member of our Board since 2015. Mr. Leonard served as our Chief Executive Officer from 2015 until March 2023. Prior to joining us, Mr. Leonard served as the President of Medical Systems for CareFusion Corporation, where he led the $2.4 billion revenue global medical device segment, which includes Alaris(r) infusion pumps, Pyxis(r) automated dispensing and patient ident…read full bio

AKILI INC (AKLI)
Leaving: CEO – Walter Edward Martucci II ( 1.2 yrs; -88.0% TSR)
Replaced by: Matthew Franklin

Matthew Franklin , age 49, has served as our President and Chief Operating Officer since August 2022. Mr. Franklin served in the same capacity at legacy Akili from June 2022 until August 2022. Prior to joining us, from January 2021 to June 2022, Mr. Franklin served as General Manager of the Precision Oncology business unit at Exact Sciences Corp., a publicly traded molecular diagnostics company….read full bio

AMERICAS CARMART INC (CRMT)
Leaving: CEO – Jeffrey A Williams ( 5.8 yrs; 12.7% TSR)
Replaced by: Douglas W Campbell Jr

Mr. Campbell will continue to serve as President of the Company upon his appointment as CEO. Mr. Campbell, age 47, has served as President of the Company since October 2022. Prior to joining the Company, Mr. Campbell was Senior Vice President, Head of Fleet Services for the Americas, at Avis Budget Group (“Avis”) since June 2022 and previously served as Head of Fleet Services for the Americas sin…read full bio

ATLANTIC COASTAL ACQUISITION CORP (ACAH)
Leaving: CEO – Shahraab Ahmad ( 2.8 yrs; 1.9% TSR)
Replaced by: Anthony Porcheron

Anthony (Tony) Porcheron, Chief Executive Officer Anthony (Tony) Porcheron, age 54, has been Managing Director and Chief Executive Officer of Porche Capital LTD, a business consulting and asset management company in Dublin, Ireland since January 2023. From May 2021 to January 2023, he was Managing Director of PK Asset Management, a business consulting and asset management company in Dublin, Irela…read full bio

ATSI COMMUNICATIONS INC (AI1)
Leaving: CEO – Arthur L Smith ( .4 yrs; )
Replaced by: Craig Kendall Clement

Craig K. Clement (64) is the Executive Chairman of Digerati Technologies. Craig has over thirty-five years of executive and director experience with Technology (telecom, Internet software) and Oil Exploration and Production (E&P) entities where he has been responsible for asset management, acquisitions and divestitures, strategic and tactical planning, financial operations, corporate finance, lega…read full bio

CENTRAL GARDEN & PET CO (CENT)
Leaving: CEO – Timothy P Cofer ( 4.0 yrs; 12.1% TSR)
Replaced by: Mary Beth Springer

Ms. Springer, age 59, has served as the Company’s lead independent director since October 2020. From 2009 to 2011, Ms. Springer served as Executive Vice President and General Manager of The Clorox Company. She served as Clorox’s Group Vice President – Strategy and Growth from 2007 until 2009. She was Group Vice President and General Manager, Specialty Division from 2005 to 2007 and Vice President …read full bio

EUROPEAN WAX CENTER INC (EWCZ)
Leaving: CEO – David P Berg ( 2.1 yrs; -9.0% TSR)
Replaced by: David L Willis

David L. Willis has served as our President and Chief Operating Officer since March 2023. Previously, he was our Chief Operating Officer and Chief Financial Officer from January 2022 to March 2023. Mr. Willis joined the Company as our Chief Financial Officer in July 2016. Prior to joining the Company, Mr. Willis served as an Operating Partner for Riata Capital Group, LLC from October 2014 to July …read full bio

FRESH TRACKS THERAPEUTICS INC (FRTX)
Leaving: CEO – Andrew D Sklawer ( .8 yrs; -48.2% TSR)
Replaced by: Albert N Marchio II

Albert N. Marchio, II, Chief Financial Officer Mr. Marchio has been with Danforth Advisors since May 2019, providing financial consulting services on a project/interim basis for public (CytomX Therapeutics, Inc. (Nasdaq: CTMX)) and various private life sciences companies. Previously, Mr. Marchio served in various finance and accounting roles at Edge Therapeutics, Inc. (now known as PDS Biotechnolo…read full bio

HORTON D R INC (DHI)
Leaving: CEO – David V Auld ( 9.0 yrs; 21.1% TSR)
Replaced by: Paul J Romanowski

Paul J. Romanowski Executive Vice President and Co-Chief Operating Officer Mr. Romanowski, age 52, is Executive Vice President and Co-Chief Operating Officer of D.R. Horton, positions he has held since October 1, 2021. Mr. Romanowski was Region President overseeing the Company’s homebuilding operations in Florida and the Gulf Coast from 2014 to 2021, and in 2019 his oversight responsibilities were…read full bio

IMMUNOME INC (IMNM)
Leaving: CEO – Purnanand D Sarma ( 4.3 yrs; -16.7% TSR)
Replaced by: Clay B Siegall

Clay Siegall, Ph.D. has served as Morphimmune’s President and Chief Executive Officer since January 2023. From November 2002 to May 2022, Dr. Siegall served as the Chief Executive Officer of Seagen, Inc. (Nasdaq: SGEN), which he co-founded in July 1997. Dr. Siegall also served as a director of Seagen, Inc. (Nasdaq: SGEN) from December 1997 to May 2022, as its President from June 2000 to May 2022 a…read full bio

KEZAR LIFE SCIENCES INC (KZR)
Leaving: CEO – John Franklin Fowler ( 8.7 yrs; -39.7% TSR)
Replaced by: Christopher J Kirk

Christopher Kirk, Ph.D. is our co-founder and has served as a member of our Board since February 2015. Dr. Kirk previously served as our President and Chief Scientific Officer from March 2015 to April 2023. Prior to founding our company, Dr. Kirk was the Vice President of Research at Onyx Pharmaceuticals, Inc., from April 2010 to April 2014. Dr. Kirk previously served as Director of Pharmacology a…read full bio

LAZARD LTD (LAZ)
Leaving: CEO – Kenneth M Jacobs ( 13.8 yrs; 2.6% TSR)
Replaced by: Peter Richard Orszag

Mr. Orszag became Chief Executive Officer of the Firm’s Financial Advisory business in June 2019. Prior to such time, he was the Firm’s Head of North American Mergers & Acquisitions since July 2018 and Global Co-Head of Healthcare since November 2016. Mr. Orszag joined the Firm in May 2016 as a Vice Chairman of Investment Banking from Citigroup, where he was Vice Chairman of Corpor…read full bio

NEAR INTELLIGENCE INC (NIR)
Leaving: CEO – Anil Mathews ( .6 yrs; -97.1% TSR)
Replaced by: Gladys Kong

Ms. Kong has served as Chief Operating Officer and Secretary of the Company since March 2023. Ms. Kong joined the Company’s predecessor (” Legacy Near “) in April 2021 in connection with Legacy Near’s acquisition of UberMedia, where she served as Chief Executive Officer from September 2015 to April 2021 and Chief Technology Officer from 2012 to 2017. Ms. Kong served as Chief Executive Officer of N…read full bio

PERFICIENT INC (PRFT)
Leaving: CEO – Jeffrey S Davis ( 20.8 yrs; 23.4% TSR)
Replaced by: Thomas J Hogan

Thomas J. Hogan was appointed as the Company’s President in February 2021 and began serving as our COO in 2018. Mr. Hogan joined the Company in January 2008 and has served the Company in several capacities, including Vice President of Field Operations, General Manager, Director of Business Development, and Engagement Director. Prior to joining the Company, Mr. Hogan served in business development …read full bio

PHENOMEX INC (CELL)
Leaving: CEO – Siddhartha Kadia ( 1.6 yrs; -73.2% TSR)
Replaced by: TBD


PITNEY BOWES INC (PBI)
Leaving: CEO – Marc Bradley Lautenbach ( 10.8 yrs; -7.0% TSR)
Replaced by: Jason Dies

Mr. Dies, age 53, has served as the Company’s Executive Vice President since October 2017 and Group Executive since January 2023, in which role he is responsible for managing the Company’s Sending Technology Solutions (SendTech) and Presort Services business units, as well as the functional groups of Human Resources, Information Technologies, Marketing and Communications. Previously, Mr. Dies serv…read full bio

SPIRIT AEROSYSTEMS HOLDINGS INC (SPR)
Leaving: CEO – Tom Gentile ( 7.1 yrs; -11.6% TSR)
Replaced by: Patrick M Shanahan

Patrick M. Shanahan 60 2021 Mr. Shanahan has policy, defense, cybersecurity, and operations experience, as well as a valuable customer perspective. Serving most recently as Acting Secretary of Defense and previously as the 33 rd Deputy Secretary of Defense, he spearheaded modernization in cybersecurity and other critical areas. Mr. Shanahan spent over three decades in a variety of lead…read full bio

SPS COMMERCE INC (SPSC)
Leaving: CEO – Archie C Black ( 22.8 yrs; 27.1% TSR)
Replaced by: Chadwick Collins

Mr. Collins, age 47, will join the Company from Körber Supply Chain, a global provider of a wide range of end-to-end supply chain solutions, where he has served as Chief Executive Officer, Software, since August 2017. Previously, he served in various roles, including President and Chief Executive Officer, at HighJump Software, a global provider of supply chain managem…read full bio

VALVOLINE INC (VVV)
Leaving: CEO – Samuel J Mitchell ( 7.0 yrs; 6.4% TSR)
Replaced by: Lori Ann Flees

Lori A. Flees has served as Valvoline’s Senior Vice President and President, Retail Services since April 2022. Prior to joining Valvoline, Ms. Flees held leadership positions at Walmart Inc., serving as Senior Vice President and Chief Operating Officer of Health & Wellness from August 2020 to March 2022; Senior Vice President and General Merchandising Manager, Sam’s Club Health & Wellness from Jun…read full bio

 

CFO Moves

AMERICAN ELECTRIC POWER CO INC (AEP)
Leaving: CFO – Ann P Kelly ( .8 yrs; -5.6% TSR)
Replaced by: Charles E Zebula

Mr. Zebula, age 63, has been Executive Vice President – Portfolio Optimization of the Company since July 2021 and has been responsible for significant strategic actions to de-risk and simplify AEP’s business profile. Prior to that, Mr. Zebula served as AEP’s Executive Vice President – Energy Supply (January 2013-July 2021) and Senior Vice President Investor R…read full bio

ATLANTIC COASTAL ACQUISITION CORP (ACAH)
Leaving: CFO – Jason Chryssicas ( 1.5 yrs; 4.5% TSR)
Replaced by: Khash Erdene Gantumur

Khash–Erdene Gantumur, Chief Financial Officer Khash–Erdene Gantumur, age 41, has been CEO of the Mongolian Central Trading Exchange LLC, of which he was the founder, since June 2016. From May 2019 to November 2019, he was CFO of Chinggis Khaan Bank in Mongolia. From June 2018 to December 2018, Mr. Gantumur was an Independent Consultant of ADB to analyze Government Budget efficiency , the Minis…read full bio

AXCELIS TECHNOLOGIES INC (ACLS)
Leaving: CFO – Kevin J Brewer ( 10.3 yrs; 36.2% TSR)
Replaced by: James Coogan

Until August 28, 2023, Mr. Coogan served as Senior Vice President, Chief Financial Officer at Kaman Corporation, a leading provider of aerospace and defense products. Since joining Kaman Corporation in 2008, Mr. Coogan held various management positions, including Vice President, Investor Relations and Corporate Development, Assistant Vice President, External Reporting and SEC …read full bio

AXONICS INC (AXNX)
Leaving: CFO – Danny L Dearen ( 10.0 yrs; 30.8% TSR)
Replaced by: Kari Keese

Ms. Keese, age 38, currently serves as the Company’s Vice President of Finance and Accounting, a role she has held since 2019 and previously served as the Company’s Director of Finance and Controller from 2014 to 2019. Prior to joining the Company, Ms. Keese served as Controller at Vessix Vascular, Inc. from 2012 to 2014, and began her career in public accounting. Ms.&nb…read full bio

CARLYLE GROUP INC (CG)
Leaving: CFO – Curtis L Buser ( 9.3 yrs; 5.4% TSR)
Replaced by: John C Redett

John C. Redett, 55, Head of Global Financial Services, will become Chief Financial Officer and Head of Corporate Strategy, effective October 1, 2023. Mr. Redett joined Carlyle in 2007 as an investor on the Global Financial Services team. He has served as the sole Head of Global Financial Services since 2020 and was the Co-Head of Global Financial Services from 2016 to 2020. Prior to joining Carlyl…read full bio

FARMER BROTHERS CO (FARM)
Leaving: CFO – Scott Ray Drake ( 3.6 yrs; -37.1% TSR)
Replaced by: Brad Bollner

Mr. Bollner, 51, has served as the Company’s Vice President of Finance since October 2022. During his more than 25-year finance career, Mr. Bollner has served as Director of Business Analytics at Dave and Busters, Senior Director of Finance at Vail Resorts, Inc. and Vice President – Inventory Planning and Allocation at GameStop Corp. He holds a Bachelor of Science degree in finance and…read full bio

INVITAE CORP (NVTA)
Leaving: CFO – Robert Dickey ( .2 yrs; )
Replaced by: Ana J. Schrank

Ms. Schrank, age 57, served as Chief Financial Officer of Truepill, Inc., a digital health platform for fulfillment and delivery, from April 2022 to January 2023. Prior to that, from December 2020 to March 2022, Ms. Schrank served as Chief Financial Officer of Collective Health, a third-party administrator integrating plan administration, navigation and advocacy. Ms. Schrank served in various capa…read full bio

SCHNEIDER NATIONAL INC (SNDR)
Leaving: CFO – Stephen L Bruffett ( 5.4 yrs; 3.9% TSR)
Replaced by: Darrell Campbell

Mr. Campbell, age 45, has served as Group Vice President of Strategy and Finance for JM Family Enterprises, a private diversified automotive company, since December 2022, where he oversaw enterprise strategy, strategic planning, treasury, and tax activities. Before working at JM Family Enterprises, Mr. Campbell served as CFO of Carnival Cruise Line of the Carnival Corporation & PLC, a cruise l…read full bio

SELECT MEDICAL HOLDINGS CORP (SEM)
Leaving: CFO – Martin F Jackson ( 16.7 yrs; 8.8% TSR)
Replaced by: Michael F Malatesta

Mr. Malatesta is a certified public account and has served in various financial and accounting roles at Select since 1999….read full bio

SEMTECH CORP (SMTC)
Leaving: CFO – Emeka Chukwu ( 16.9 yrs; 4.0% TSR)
Replaced by: Mark Lin

Mr. Lin, age 47, has served as Vice President and Corporate Controller of MKS Instruments, Inc., a global provider of foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications since November 2019. Previously, Mr. Lin was with Microsemi Corporation, a provider of semiconductor and system solutions, from …read full bio

SYMBOTIC INC (SYM)
Leaving: CFO – Thomas C Ernst Jr ( 1.5 yrs; 133.6% TSR)
Replaced by: Carol J Hibbard

Ms. Hibbard, age 56, joins the Company from The Boeing Company, a major aerospace firm, where she served as Senior Vice President and Controller since April 2021. Previously, Ms. Hibbard held various strategic and financial roles with The Boeing Company, including Vice President and Chief Financial Officer of Boeing Defense, Space & Security (“BDS”) from May 2017 thr…read full bio

TINGO GROUP INC (TIO)
Leaving: CFO – Kevin Hao Chen ( 1.9 yrs; -9.9% TSR)
Replaced by: Amir Ayalon

Mr. Ayalon succeeds Kevin Chen, who will remain with the Company as its Chief Financial Officer for its Asia-Pacific operations. Mr. Ayalon, age 55, has over 20 years of cross-industrial involvement in global financial advisory and investment, as well as operational management roles within corporates, hedge funds and investment banks. Mr. Ayalon’s operational experience spans a variety of industri…read full bio

TOMPKINS FINANCIAL CORP (TMP)
Leaving: CFO – Francis M Fetsko ( 22.8 yrs; 7.4% TSR)
Replaced by: Matthew Tomazin

Mr. Tomazin, age 38, has served as Senior Vice President and Treasurer of the Company and the Bank since February 2021, having joined the Company in April 2019 as Vice President and Senior Quantitative Analyst. From 2008 until April 2019, Mr. Tomazin served in accounting and strategic finance roles, most recently as Vice President and Assistant Treasurer with NBT Bancorp Inc. (NASDAQ: NBTB), …read full bio

TRUECAR INC (TRUE)
Leaving: CFO – Teresa Luong ( .7 yrs; -22.0% TSR)
Replaced by: Oliver Foley

Mr. Foley, age 39, is joining the Company after having served Flexcar, LLC, a vehicle subscription company, as its Head of Finance since October 2022 and as Regional General Manager from January 2022 to September 2022. Before joining Flexcar, Mr. Foley was the Vice President of Strategy, Society6 at Leaf Group, Ltd., a diversified Internet, media and e-commerce company, from December 2018 to Febru…read full bio

VIAVI SOLUTIONS INC (VIAV)
Leaving: CFO – Henk Derksen ( 2.6 yrs; -19.0% TSR)
Replaced by: Pamela K Avent

Pamela Avent was appointed Interim Chief Financial Officer in September 2023, effective October 1, 2023. Prior to her appointment as Interim Chief Financial Officer, Ms. Avent served as Vice President, Internal Audit from November 9, 2015 and as Global Controller from May 1, 2019. She also served as interim Chief Financial Officer of the Company from November 2020 to March 2021. Prior to joining t…read full bio

 

Director Joins

AADI BIOSCIENCE INC (AADI)
David James Lennon
Prior to joining the Company, Dr. Lennon, 52, served as Chief Executive Officer of Satellite Bio, a privately held regenerative medicine company, from July 2021 to September 2023. Prior to that, Dr. Lennon spent more than 15 years with Novartis AG, where he served most recently as Pre…read full bio

AARON’S COMPANY INC (AAN)
Wangdali Bacdayan
Mr. Bacdayan is a private investor and entrepreneur. He also currently serves as a Venture Partner for Delta-v Capital, a technology-focused growth capital investment firm. In addition, he is the principal investor and co-founder of Millie’s Homemade Ice Cream and Southern Steer Franchising. P…read full bio

ACCO BRANDS CORP (ACCO)
Thomas W Tedford
Mr. Tedford joined ACCO Brands in 2010 and was named President and Chief Operating Officer in 2021. From 2011 to 2021, Mr. Tedford served first as Executive Vice President and President of ACCO Brands Americas ultimately becoming Executive Vice President and President, ACCO Brands, North America. Du…read full bio

AKILI INC (AKLI)
Matthew Franklin
Matthew Franklin , age 49, has served as our President and Chief Operating Officer since August 2022. Mr. Franklin served in the same capacity at legacy Akili from June 2022 until August 2022. Prior to joining us, from January 2021 to June 2022, Mr. Franklin served as General Manager of the Precisio…read full bio

ANNALY CAPITAL MANAGEMENT INC (NLY)
Manon Laroche
Ms. Laroche served as Managing Director, Head of Global Spread Products Securitized Sales, North America at Citigroup, a global financial services company, from 2018 to February 2023. Prior to this, Ms. Laroche served as Head of Global Securitized Markets Sales, New York beginning in 2012. From 2002…read full bio

ANNALY CAPITAL MANAGEMENT INC (NLY)
Scott Wede
Mr. Wede served as the Global Head of Securitized Products and Municipal Finance at Barclays Capital from 2004 to 2015. More recently, Mr. Wede served as the President and Chief Financial Officer of Conventus Holdings Corp., a provider of business purpose loans, from January 2022 to April 2022. Mr. …read full bio

ATLANTIC COASTAL ACQUISITION CORP (ACAH)
Chandra Panchal
Dr. Chandra Panchal, age 74, is the founder of Axcelon Biopolymers Corp., a biotechnology company where he has been Chairman, CEO and Chief Scientific Officer since 2008. From 1989 to 1999 he was Co-Founder, President, and Chief Executive Officer of Procyon Biopharma Inc., which he took public …read full bio

ATLANTIC COASTAL ACQUISITION CORP (ACAH)
Anthony Porcheron
Anthony (Tony) Porcheron, Chief Executive Officer Anthony (Tony) Porcheron, age 54, has been Managing Director and Chief Executive Officer of Porche Capital LTD, a business consulting and asset management company in Dublin, Ireland since January 2023. From May 2021 to January 2023, he was Managing …read full bio

ATLANTIC COASTAL ACQUISITION CORP (ACAH)
Bartholomew Pan-Kita
Bartholomew Pan-Kita, age 59, has been Managing Director, Global Head of Capital Markets, Special Situations & Merchant Banking of Univest Securities LLC since 2021. He was Managing Director, Global Head of Debt Capital Markets & Special Situations, of Maxim Group LLC from 2016 to 2021. From…read full bio

ATLANTIC COASTAL ACQUISITION CORP (ACAH)
Tseren Purev
Tseren Purev, Independent Director Tseren Purev, age 63, has over 30 years of experience in corporate and government biotech experience in Mongolia, Russia, China, Ukraine, the United Kingdom, Australia and throughout Asia. Mr. Purev is experienced in animal biotechnologies, developing expression s…read full bio

BUMBLE INC (BMBL)
Sissie L Hsiao
In her current role at Google, Ms. Hsiao is the Vice President and General Manager of Google Assistant and Bard (since April 2021), leading many of Google’s advancements applying AI, natural language, and speech technologies to consumer products. Prior to this role, she was responsible as…read full bio

CENCORA INC (COR)
Werner Baumann
Prior to his retirement in May 2023, Mr. Baumann served as Chief Executive Officer and Chairman of the Board of Management of Bayer AG, a global enterprise with core competencies in the life science fields of health care and nutrition, since May 2016, and as Chief Sustainability …read full bio

CENTERPOINT ENERGY INC (CNP)
Thaddeus Malik
Mr. Malik, 56, is Principal at S2T Solutions, LLC, a transactional advisory services company, since 2022. Prior to joining S2T Solutions, Mr. Malik served as a partner at Paul Hastings, LLP, a global law firm, from 2010 to 2022, and as a partner at Jenner & Block, LLP, a global law firm, from 20…read full bio

CENTERPOINT ENERGY INC (CNP)
Ricky Raven
Mr. Raven, 62, is Senior Vice President and Deputy General Counsel at Allstate Insurance Company, a publicly traded property and casualty insurer, since August 2021. Prior to joining Allstate Insurance Company, Mr. Raven was a partner at Reed Smith LLP, an international law firm, from…read full bio

ELASTIC NV (ESTC)
Paul R Auvil III
Paul Auvil Background and Experience Paul Auvil was nominated for appointment to our board of directors and is standing for appointment at the Annual Meeting. * From March 2007 to February 2023, Mr. Auvil served as the CFO of Proofpoint, Inc., an enterprise security company that provides software a…read full bio

ELEDON PHARMACEUTICALS INC (ELDN)
James A Robinson Jr
Mr. Robinson currently serves on the Board of Directors of UroGen Pharma (Nasdaq: URGN). He previously served on the Board of Directors for Neos Therapeutics and for AGTC before the company was sold to Syncona. Mr. Robinson also previously served on the Board of Directors of the Pharmaceutical Resea…read full bio

ELEDON PHARMACEUTICALS INC (ELDN)
Allan Kirk
Dr. Kirk served as the inaugural Chief of the Transplantation Branch for the National Institute of Diabetes and Digestive and Kidney Diseases and has been a principal investigator for multiple clinical trials, including the first-in-human experience with novel immunosuppressive agents. Dr. Kirk has …read full bio

ELEDON PHARMACEUTICALS INC (ELDN)
Allan Douglas Kirk
Dr. Kirk served as the inaugural Chief of the Transplantation Branch for the National Institute of Diabetes and Digestive and Kidney Diseases and has been a principal investigator for multiple clinical trials, including the first-in-human experience with novel immunosuppressive agents. Dr. Kirk has …read full bio

EUROPEAN WAX CENTER INC (EWCZ)
David L Willis
David L. Willis has served as our President and Chief Operating Officer since March 2023. Previously, he was our Chief Operating Officer and Chief Financial Officer from January 2022 to March 2023. Mr. Willis joined the Company as our Chief Financial Officer in July 2016. Prior to joining the Compan…read full bio

F5 INC (FFIV)
Michel Combes
Michel Combes , age 58, has served as one of our directors since July 2018. Mr. Combes joined SoftBank Group International, a conglomerate holding company, in June 2020 as President. Prior to joining SoftBank Group International, he served as President and Chief Executive Officer of Sprint, a public…read full bio

FLOWERS FOODS INC (FLO)
Brigitte King
Brigitte King is the global chief digital officer at Colgate-Palmolive Company, where she oversees digital commerce, digital marketing and omnichannel brand strategies. King has extensive digital and consumer marketing experience, and held senior roles at PVH Corp. and at L’Oréal, …read full bio

FRESH TRACKS THERAPEUTICS INC (FRTX)
Albert N Marchio II
Albert N. Marchio, II, Chief Financial Officer Mr. Marchio has been with Danforth Advisors since May 2019, providing financial consulting services on a project/interim basis for public (CytomX Therapeutics, Inc. (Nasdaq: CTMX)) and various private life sciences companies. Previously, Mr. Marchio ser…read full bio

HOWMET AEROSPACE INC (HWM)
Gunner Smith
Mr. Smith is currently the President of Owens Corning’s roofing business. He became a member of the Executive Committee of Owens Corning in August 2018. Prior to 2018, Mr. Smith served as the Vice President of Distribution and Home Center Sales for the roofing business at Owens Corning. From 2…read full bio

IMMUNOME INC (IMNM)
Clay B Siegall
Clay Siegall, Ph.D. has served as Morphimmune’s President and Chief Executive Officer since January 2023. From November 2002 to May 2022, Dr. Siegall served as the Chief Executive Officer of Seagen, Inc. (Nasdaq: SGEN), which he co-founded in July 1997. Dr. Siegall also served as a director of Seage…read full bio

IMMUNOME INC (IMNM)
Isaac Barchas
Barchas and Rosett and entities affiliated with EcoR1 Capital, LLC, Redmile Group, LLC and Mr. Barchas were parties to these agreements….read full bio

IMMUNOME INC (IMNM)
James P. Boylan
James Boylan has served as the chief executive officer of Enavate Sciences, a portfolio company of Patient Square Capital that provides capital and strategic growth support to biotech and life science companies, since May 2022. Previously, Mr. Boylan served as President and Head of Investment Bankin…read full bio

LAZARD LTD (LAZ)
Peter Richard Orszag
Mr. Orszag became Chief Executive Officer of the Firm’s Financial Advisory business in June 2019. Prior to such time, he was the Firm’s Head of North American Mergers & Acquisitions since July 2018 and Global Co-Head of Healthcare since November 2016. Mr. Orszag joined the Firm in Ma…read full bio

LAZYDAYS HOLDINGS INC (LAZY)
Susan Scarola
Ms. Scarola has over 30 years of leadership experience, including serving as Chief Executive Officer, Chief Financial Officer, President and Vice Chair of DCH Auto Group, a multi-state automotive dealer. Ms. Scarola retired in June 2015, and currently serves on the advisory board and compensation co…read full bio

LAZYDAYS HOLDINGS INC (LAZY)
Suzanne Tager
Ms. Tager has served as Executive Vice President, Chief of Staff to Worldwide Managing Partner at Bain & Company since January 2020. Prior to that, Ms. Tager served as Executive Vice President, Global Retail and Consumer Products from April 2007 to December 2019. Ms. Tag…read full bio

ORANGE COUNTY BANCORP INC (OBT)
Olga Luz Tirado
Tirado is president of O Communications & Solutions, Inc., a minority- and women-owned public relations and branding  agency she founded in 2017. She previously spent 10 years leading The Bronx Tourism Council (BTC), where she launched a successful campaign to connect local cultural partner…read full bio

RACKSPACE TECHNOLOGY INC (RXT)
Thomas L Cole
Cole also spent 20 years in investment banking with Deutsche Bank, primarily in client service, origination and risk management. Mr. Cole started his career in General Electric’s financial management program and as an associate at Continental Bank. and he also spent several years at HSBC. He serves …read full bio

RAYONIER ADVANCED MATERIALS INC (RYAM)
Bryan D. Yokley
Yokley retired from EY in June 2022, where he spent 34 years serving in various capacities, including Audit Partner in Georgia, New York, Australia, Sweden, California, and North Carolina. He also served on EY’s governing board for two terms and was the market leader for Alabama, Georgia …read full bio

REINSURANCE GROUP OF AMERICA INC (RGA)
Michele Bang
Ms. Bang, 59, is the former Deputy Chief Executive Officer of Eastspring Investments Group, the Asia asset management arm of Prudential Corporation Asia. During her time with Prudential, she concurrently served as a founding executive team member of Prudential’s first health and wealth co…read full bio

SAB BIOTHERAPEUTICS INC (SABS)
Andrew D. Moin
Andrew Moin is a Partner and Analyst at Sessa Capital, a New York based investment advisor registered with the SEC. Mr. Moin has been with Sessa since 2012, where he works on idea generation, research, and investment implementation. Prior to Sessa, from 2008-2012, Mr. Moin was in the Tax Group at Su…read full bio

SONDER HOLDINGS INC (SOND)
M Thomas Buoy
Mr. Buoy has over 30 years of experience in the hospitality sector, and is currently President and Chief Executive Officer of his own commercial consulting and advisory business, Revenue Buoy, LLC, which he formed in 2020, specializing in marketing, sales, revenue management, distribu…read full bio

SONDER HOLDINGS INC (SOND)
Simon Turner
Mr. Turner has over 35 years of experience in the hospitality and real estate sectors, having held senior executive roles and board seats in both public and private enterprises. In 2017, he formed Alpha Lodging Partners to make selective investments, and to provide strategic and transactional adviso…read full bio

SONDER HOLDINGS INC (SOND)
Tom Buoy
Buoy and Turner qualifies as an “independent director” under the applicable Nasdaq Stock Market rules. Mr. Buoy has over 30 years of experience in the hospitality sector, and is currently President and Chief Executive Officer of his own commercial consulting and advisory business, Revenue Buoy, LLC,…read full bio

SPS COMMERCE INC (SPSC)
Chadwick Collins
Mr. Collins, age 47, will join the Company from Körber Supply Chain, a global provider of a wide range of end-to-end supply chain solutions, where he has served as Chief Executive Officer, Software, since August 2017. Previously, he served in various roles, including Preside…read full bio

TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
Boyd Vindell Washington
Dr. Washington has served in various roles at Verily, an Alphabet backed health technology company focused on research, care and health financing, since January 2020, including Chief Clinical Officer for Care, leading the newly formed Health Equity Center of Excellence for Verily, Chi…read full bio

TINGO GROUP INC (TIO)
C. Derek Campbell
Mr. Campbell, age 55, is an experienced senior executive leader and strategic advisor with business interests across the energy, natural resources, infrastructure, security, and defense sectors. He has held the position of Group Managing Partner of LVC Global Holdings, LLC, since its inception in 20…read full bio

VALVOLINE INC (VVV)
Lori Ann Flees
Lori A. Flees has served as Valvoline’s Senior Vice President and President, Retail Services since April 2022. Prior to joining Valvoline, Ms. Flees held leadership positions at Walmart Inc., serving as Senior Vice President and Chief Operating Officer of Health & Wellness from August 2020 to March …read full bio

 

Director Leaves

ADTRAN HOLDINGS INC (ADTN)
Johanna Hey ( 1.2 yrs; -46.2% TSR)
Committees: Audit, Environmental, Social and Governance

AGILITI INC (AGTI)
Thomas W Boehning ( .5 yrs; -58.9% TSR)


AKA BRANDS HOLDING CORP (AKA)
Simon Andrew Beard ( 1.8 yrs; -81.8% TSR)


AMERICAN ELECTRIC POWER CO INC (AEP)
Nicholas K Akins ( 12.0 yrs; 10.1% TSR)
Committees: Executive, Policy

AMPLIFY ENERGY CORP (AMPY)
Randal T Klein ( 5.5 yrs; .6% TSR)
Committees: Audit, Compensation

APOLLO GLOBAL MANAGEMENT INC (APO)
Richard P Emerson ( 1.8 yrs; 41.6% TSR)
Committees: Compensation

APOLLO GLOBAL MANAGEMENT INC (APO)
Richard P Emerson ( 1.8 yrs; 17.7% TSR)
Committees: Compensation

ATLAS ENERGY SOLUTIONS INC (AESI)
Mark P Mills ( .8 yrs; 42.4% TSR)


ATLAS ENERGY SOLUTIONS INC (AESI)
Stacy Hock ( .8 yrs; 42.4% TSR)


ATLAS ENERGY SOLUTIONS INC (AESI)
Robb L Voyles ( .8 yrs; 42.4% TSR)


ATLAS ENERGY SOLUTIONS INC (AESI)
Douglas Rogers ( .8 yrs; 42.4% TSR)


ATLAS ENERGY SOLUTIONS INC (AESI)
Gayle Burleson ( .8 yrs; 42.4% TSR)


ATLAS ENERGY SOLUTIONS INC (AESI)
A Lance Langford ( .8 yrs; 42.4% TSR)


ATLAS ENERGY SOLUTIONS INC (AESI)
Gregory M Shepard ( .8 yrs; 42.4% TSR)


BITNILE METAVERSE INC (BNMV)
Steven K Nelson ( 6.4 yrs; -64.6% TSR)


DARDEN RESTAURANTS INC (DRI)
Eugene I Lee Jr ( 8.7 yrs; 14.5% TSR)


DELTA AIR LINES INC (DAL)
George N Mattson ( 11.0 yrs; 15.1% TSR)
Committees: Finance, Nominating (and Governance), Personnel and Compensation

DENTSPLY SIRONA INC (XRAY)
Harry M Jansen Kraemer Jr ( 7.9 yrs; -6.1% TSR)
Committees: Nominating (and Governance)

ELASTIC NV (ESTC)
Jonathan Chadwick ( 5.2 yrs; 4.1% TSR)
Committees: Audit, Compensation

ENOVIX CORP (ENVX)
Emmanuel T Hernandez ( 2.8 yrs; 3.7% TSR)


FARMER BROTHERS CO (FARM)
D Deverl Maserang ( 4.0 yrs; -34.6% TSR)


G1 THERAPEUTICS INC (GTHX)
Mark A Velleca ( 9.3 yrs; -31.7% TSR)


GUESS INC (GES)
Maurice Marciano ( 33.7 yrs; 10.2% TSR)


IGM BIOSCIENCES INC (IGMS)
Michael D Loberg ( 8.1 yrs; -22.1% TSR)
Committees: Audit, Compensation, Nominating (and Governance), Research and Clinical Development

IMMUNOME INC (IMNM)
Michael Rapp ( 7.8 yrs; -16.7% TSR)


IMMUNOME INC (IMNM)
Purnanand D Sarma ( 4.3 yrs; -16.7% TSR)


IMMUNOME INC (IMNM)
Richard A Baron ( 3.1 yrs; -16.7% TSR)


IMMUNOME INC (IMNM)
John L Lamattina ( 6.0 yrs; -16.7% TSR)


IMMUNOME INC (IMNM)
Michael Lefenfeld ( 6.0 yrs; -16.7% TSR)


KEZAR LIFE SCIENCES INC (KZR)
John Franklin Fowler ( 8.8 yrs; -39.7% TSR)


NEOGEN CORP (NEOG)
Darci L Vetter ( 6.0 yrs; -5.3% TSR)
Committees: Compensation, Nominating (and Governance)

OMEGA FLEX INC (OFLX)
Mark F Albino ( 27.7 yrs; 12.8% TSR)
Committees: Executive

ORTHOFIX MEDICAL INC (OFIX)
Keith Valentine ( .8 yrs; -30.5% TSR)


PHENOMEX INC (CELL)
Elizabeth A Nelson ( 4.1 yrs; -67.4% TSR)
Committees: Audit, Compensation, Nominating (and Governance), ompensation & Leadership Development

PHENOMEX INC (CELL)
John R Chiminski ( 2.4 yrs; -80.2% TSR)
Committees: Audit, Nominating (and Governance)

PHENOMEX INC (CELL)
Jessica Hopfield ( 1.8 yrs; -82.3% TSR)
Committees: Compensation, Nominating (and Governance), ompensation & Leadership Development

PHENOMEX INC (CELL)
Michael J Moritz ( 8.5 yrs; -67.4% TSR)
Committees: Compensation, Nominating (and Governance)

PHENOMEX INC (CELL)
Gregory T Lucier ( 3.3 yrs; -67.4% TSR)
Committees: Compensation, Nominating (and Governance)

PHENOMEX INC (CELL)
Peter Silvester ( .5 yrs; -24.7% TSR)
Committees: Audit, ompensation & Leadership Development

PHENOMEX INC (CELL)
Siddhartha Kadia ( 2.1 yrs; -83.0% TSR)


PHUNWARE INC (PHUN)
Eric Manlunas ( 3.8 yrs; -37.5% TSR)
Committees: Audit, Compensation

PITNEY BOWES INC (PBI)
Marc Bradley Lautenbach ( 10.8 yrs; -7.0% TSR)
Committees: Executive

PPG INDUSTRIES INC (PPG)
Michael H McGarry ( 8.8 yrs; 3.5% TSR)
Committees: Technology and Environment

PREMIER INC (PINC)
Terry Shaw ( 10.4 yrs; -2.7% TSR)
Committees: Finance, Nominating (and Governance), Special

RAYONIER ADVANCED MATERIALS INC (RYAM)
Thomas I Morgan ( 9.3 yrs; -22.7% TSR)
Committees: Compensation and Management Development, Finance and Strategic planning, Nominating (and Governance)

REDWOOD TRUST INC (RWT)
George W Madison ( 3.2 yrs; 13.4% TSR)
Committees: Audit, Nominating (and Governance)

SCIENCE APPLICATIONS INTERNATIONAL CORP (SAIC)
Nazzic S Keene ( 4.3 yrs; 7.7% TSR)
Committees: Risk Oversight

SERES THERAPEUTICS INC (MCRB)
Gregory Behar ( 8.8 yrs; -28.6% TSR)
Committees: Nominating (and Governance)

SONOS INC (SONO)
Deirdre Findlay ( 3.7 yrs; -3.5% TSR)
Committees: compensation, people and diversity & inclusion, Nominating (and Governance)

SPIRIT AEROSYSTEMS HOLDINGS INC (SPR)
Tom Gentile ( 7.2 yrs; -11.9% TSR)


SYROS PHARMACEUTICALS INC (SYRS)
Mark J Alles ( 3.8 yrs; -48.6% TSR)
Committees: Audit

TILLY’S INC (TLYS)
Bernard Zeichner ( 12.5 yrs; -2.7% TSR)
Committees: Audit, Compensation

TRUIST FINANCIAL CORP (TFC)
Frank P Scruggs Jr ( 4.0 yrs; -11.6% TSR)
Committees: Compensation and Human Capital , Risk, Trust

TRUIST FINANCIAL CORP (TFC)
Paul D Donahue ( 4.0 yrs; -11.6% TSR)
Committees: Compensation and Human Capital , Trust

TRUIST FINANCIAL CORP (TFC)
Kelly S King ( 15.3 yrs; 4.4% TSR)
Committees: Executive, Risk

TRUIST FINANCIAL CORP (TFC)
David M Ratcliffe ( 4.0 yrs; -11.6% TSR)
Committees: Executive, Nominating (and Governance), Risk

TRUIST FINANCIAL CORP (TFC)
Anna R Cablik ( 19.9 yrs; 2.2% TSR)
Committees: Compensation and Human Capital , Executive, Risk, Trust

TRUIST FINANCIAL CORP (TFC)
Easter A Maynard ( 5.2 yrs; -7.1% TSR)
Committees: Audit, Compensation, Compensation and Human Capital , Nominating (and Governance)

TRUIST FINANCIAL CORP (TFC)
Nido R Qubein ( 33.9 yrs; 3.1% TSR)
Committees: Executive, Risk,  Technology, Trust

TRUIST FINANCIAL CORP (TFC)
Thomas Nichols Thompson ( 15.9 yrs; 2.6% TSR)
Committees: Compensation, Executive, Nominating (and Governance), Risk

UNIVERSAL ELECTRONICS INC (UEIC)
Carl E Vogel ( 14.0 yrs; -5.4% TSR)
Committees: Audit

VALVOLINE INC (VVV)
Samuel J Mitchell ( 7.0 yrs; 6.4% TSR)

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.